Lymph vessel growth, also known as lymphangiogenesis, is crucial during development, wound healing, inflammation and tumour metastasis. To enable non-invasive detection and quantification of lymphangiogenesis, Martínez-Corral et al. developed a mouse model expressing an enhanced green fluorescent (EGFP)-luciferase (Luc) fusion protein under the control of endogenous VegfR3 (encoding vascular endothelial growth factor receptor 3, a lymphatic marker). VegfR3EGFPLucknock-in mice were used to visualise lymphangiogenesis during development and postnatally, when VegfR3 expression is downregulated. Additionally, growth-factor-stimulated lymphangiogenesis was visualised in live, adult mice using VEGF-C, which resulted in an eightfold increase in Luc signal compared with control mice. The authors also validated their model by visualising lymphangiogenesis during wound healing and inflammation. Finally, they demonstrated that their model is suitable for visualising tumour-induced lymph vessel growth. These mice provide a novel and highly sensitive tool to study the involvement of lymphangiogenesis in normal development and various pathological conditions.
Visualising lymphangiogenesis in vivo
Visualising lymphangiogenesis in vivo. Dis Model Mech 1 May 2012; 5 (3): 287. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists